Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

First Trust NYSE Arca Biotechnology Index Fund (FBT)

During the Trading Day
111.39 -2.12 / -1.87%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
111.39 0.00 / 0.00%
Volume: 550.00

Investment Objective

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE Arca Biotechnology Index(SM). The fund will normally invest at least 90% of its net assets (including investment borrowings) in common stocks that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. It is non-diversified.

No recent news for First Trust NYSE Arca Biotechnology Index Fund.


1 month-10.11% 3 years+37.60%
3 months-7.29% 5 years+27.65%
1 year+22.33% Since inception+20.94%
Data through 09/03/2015

Quote Details

Previous close$113.51
Open day’s range111.17 – 114.63
Net asset value (NAV)113.55 (09/02/2015)
Daily volume156,844
Average volume (3 months)188,731
Data as of 3:59pm ET, 09/03/2015

Peer Comparisonvs. Health ETFs

Performance 5-yr return+27.65%+26.72%
Expense Gross exp ratio0.58%0.46%
Risk 5 year sharpe ratio1.231.60
Net assets$3.4B$1.9B
Average market cap$9.6B$38.7B
Average P/E20.926.0
Dividend / Share--0.21%


XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
MYGN Myriad Genetics Inc4.17%
INCY Incyte Corp3.86%
Q Quintiles Transnational Holdings Inc3.77%
-- 3.74%
VRTX Vertex Pharmaceuticals Inc3.69%
GRFS Grifols SA3.66%
REGN Regeneron Pharmaceuticals3.62%
AMGN Amgen3.61%
CRL Charles River Laboratories International Inc3.56%
TECH Bio-Techne Corp3.53%

Partner Offers